ATE239502T1 - Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten - Google Patents

Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten

Info

Publication number: ATE239502T1
Authority: AT; Austria
Prior art keywords: peptides; treatment; mhc class; vaccination; molecules
Prior art date: 1992-12-17

Application number

AT94904861T

Other languages

English (en)

Inventor

Subramaniam Sriram

Bishwajit Nag

Somesh D Sharma

Original Assignee

Subramaniam Sriram

Bishwajit Nag

Somesh D Sharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-12-17

Filing date

1993-12-16

Publication date

2003-05-15

1993-12-16 Application filed by Subramaniam Sriram, Bishwajit Nag, Somesh D Sharma filed Critical Subramaniam Sriram

2003-05-15 Application granted granted Critical

2003-05-15 Publication of ATE239502T1 publication Critical patent/ATE239502T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
102000018713 Histocompatibility Antigens Class II Human genes 0.000 title abstract 2
208000023275 Autoimmune disease Diseases 0.000 title 1
108091054438 MHC class II family Proteins 0.000 title 1
238000002255 vaccination Methods 0.000 title 1
108700018351 Major Histocompatibility Complex Proteins 0.000 abstract 3
230000028993 immune response Effects 0.000 abstract 3
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract 3
102000003886 Glycoproteins Human genes 0.000 abstract 2
108090000288 Glycoproteins Proteins 0.000 abstract 2
230000002939 deleterious effect Effects 0.000 abstract 2
108700028369 Alleles Proteins 0.000 abstract 1
108010027412 Histocompatibility Antigens Class II Proteins 0.000 abstract 1
206010020751 Hypersensitivity Diseases 0.000 abstract 1
108091007491 NSP3 Papain-like protease domains Proteins 0.000 abstract 1
102000015636 Oligopeptides Human genes 0.000 abstract 1
108010038807 Oligopeptides Proteins 0.000 abstract 1
230000007815 allergy Effects 0.000 abstract 1
230000005784 autoimmunity Effects 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Pulmonology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Cell Biology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT94904861T 1992-12-17 1993-12-16 Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten ATE239502T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US99294292A	1992-12-17	1992-12-17
PCT/US1993/012351 WO1994013320A1 (en)	1992-12-17	1993-12-16	Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease

Publications (1)

Publication Number	Publication Date
ATE239502T1 true ATE239502T1 (de)	2003-05-15

Family

ID=25538911

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94904861T ATE239502T1 (de)	1992-12-17	1993-12-16	Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten

Country Status (7)

Country	Link
EP (1)	EP0674526B1 (de)
JP (1)	JPH08509204A (de)
AT (1)	ATE239502T1 (de)
AU (1)	AU5872594A (de)
CA (1)	CA2152075C (de)
DE (1)	DE69332956D1 (de)
WO (1)	WO1994013320A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6045796A (en) *	1992-12-17	2000-04-04	Anergen, Inc.	Vaccination with peptide of MHC class II molecules for treatment of autoimmune disease
EP0723458A4 (de) *	1994-06-16	1998-03-11	Univ Leland Stanford Junior	Die immunmodulation mittels fragmenten der klasse ii-alpha-untereinheit
IT1274592B (it) *	1994-08-05	1997-07-18	Angela Turiano	Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
US20030118594A1 (en) *	1995-06-07	2003-06-26	Bishwajit Nag	Stable formulations of mhc-peptide complexes
WO2000061632A1 (en) *	1999-04-12	2000-10-19	Stanford University	Interaction of mhc class ii proteins with members of the pcna family of proteins
EP1715343B1 (de) *	2005-04-20	2009-12-09	F. Hoffmann-La Roche Ag	Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1327162C (en) *	1987-04-09	1994-02-22	Board Of Trustees Of The Leland Stanford Junior University (The)	Method for prophylactically treating an individual for an autoimmune disease
WO1992016234A1 (en) *	1991-03-22	1992-10-01	The Trustees Of The University Of Pennsylvania	Method of modulating mammalian t-cell response

1993
- 1993-12-16 JP JP6514538A patent/JPH08509204A/ja not_active Ceased
- 1993-12-16 WO PCT/US1993/012351 patent/WO1994013320A1/en not_active Ceased
- 1993-12-16 DE DE69332956T patent/DE69332956D1/de not_active Expired - Lifetime
- 1993-12-16 AU AU58725/94A patent/AU5872594A/en not_active Abandoned
- 1993-12-16 CA CA002152075A patent/CA2152075C/en not_active Expired - Fee Related
- 1993-12-16 AT AT94904861T patent/ATE239502T1/de not_active IP Right Cessation
- 1993-12-16 EP EP94904861A patent/EP0674526B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2152075A1 (en)	1994-06-23
AU5872594A (en)	1994-07-04
WO1994013320A1 (en)	1994-06-23
EP0674526A1 (de)	1995-10-04
DE69332956D1 (de)	2003-06-12
CA2152075C (en)	2001-04-10
JPH08509204A (ja)	1996-10-01
EP0674526B1 (de)	2003-05-07
EP0674526A4 (de)	1997-01-15

Legal Events

Date	Code	Title	Description
2003-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69934967D1 (de)	2007-03-15	Verfahren zur verminderung der immunogenität von proteinen
GEP20022695B (en)	2002-05-27	Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
CA2290485A1 (en)	1998-11-26	Method for the production of non-immunogenic proteins
ATE415173T1 (de)	2008-12-15	Pan dr-bindeproteinen zur erhöhung der immunantwort
NO983999L (no)	1998-11-02	Peptidimmunogener for vaksinasjon mot og behandling av allergi
MX9703643A (es)	1997-08-30	Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
ES2101834T3 (es)	1997-07-16	Anticuerpos anti-cd4 que bloquean sincitios inducidos por vih.
ATE198050T1 (de)	2000-12-15	Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE69726426D1 (de)	2004-01-08	Unterdrückung von immunantwort durch hemmung von cathepsin s
ATE326981T1 (de)	2006-06-15	Isolierte peptide die aminosäuresequenzen von ny- eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE215830T1 (de)	2002-04-15	Verfahren zur detektion und behandlung von individuen mit abnormal hla-a2/tyrosinase- peptidantigenen exprimierenden zellen
ATE239502T1 (de)	2003-05-15	Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten
ATE202114T1 (de)	2001-06-15	Verwendung von peptiden welche eine immunantwort bewirken zur herstellung von medikamenten zur induzierung der immunsuppression.
DE69829995D1 (de)	2005-06-02	Multivalente rekombinante antikörper zur behandlung von hrv infektionen
ATE234358T1 (de)	2003-03-15	Peptide des pferdearteritisvirus, antikörper und ihre verwendung in einem diagnostischen test